impact factor

Approach to therapy of psoriatic arthritis


Therapy strategies in psoriatic arthritis



  1. Leeds Inst. of Rheumatic and Musculoskeletal Medicine, University of Leeds, UK and Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals Trust, UK and Div. of Allergy, Immunology and Rheumatology, Univ. of Rochester Medical Center, USA.

2015 Vol.33, N°5 ,Suppl.93
PI 0070, PF 0072
Approach to therapy of psoriatic arthritis

Free to view
(click on article PDF icon to read the article)

PMID: 26470949 [PubMed]

Received: 19/08/2015
Accepted : 20/08/2015
In Press: 15/10/2015
Published: 16/10/2015


Psoriatic arthritis (PsA) is a heterogeneous condition with a myriad of different clinical presentations. It commonly affects the skin and musculoskeletal system causing psoriasis, peripheral arthritis, axial arthritis, enthesitis and dactylitis. Many patients also have related conditions, such as those within the metabolic syndrome and associated spondyloarthritis (SpA) conditions including inflammatory bowel disease and uveitis. Any therapeutic strategy must be tailored to the individual patient, taking into account her/his complete clinical presentation and comorbidities. New treatment recommendations from the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) provide evidence based recommendations on effective therapies for the management of each different manifestation of PsA, and how treatment may be affected by comorbidities (1). However, the limited evidence comparing different treatment strategies in PsA is recognised as a limitation in these recommendations and further information is detailed below.

Rheumatology Article